Domino’s Russian Franchisee Halts Royalties

The Russian franchisee of Domino’s Pizza Inc (NYSE:DPZ) has paused royalty payments from its restaurants in Russia, Reuters reported. The franchisee…

byShivani Kumaresan

March 11, 2022

1 minute read

The Russian franchisee of Domino’s Pizza Inc (NYSE:DPZ) has paused royalty payments from its restaurants in Russia, Reuters reported.
The franchisee will also stop further investments in the country following Moscow’s invasion of Ukraine.
Netherlands-based DP Eurasia NV is the independent franchisee of Domino’s in Russia.
Price Action: DPZ shares are trading lower by 1.52% at $387.17 on the last check Friday.

SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems

By Benzinga Newsdesk

Today, 10:52 PM

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company" or "SciSparc"),SciSparc Ltd.

SPRC

Rush Enterprises Q1 Adj. EPS $1.43 Beats $1.02 Estimate, Sales $1.56B Beat $1.38B Estimate

By Benzinga Newsdesk

Today, 10:52 PM

Rush Enterprises (NASDAQ:RUSHA) reported quarterly earnings of $1.43 per share which beat the analyst consensus estimate of $1.02 by 40.2 percent. This is a 81.01 percent increase over earnings of $0.79 per share from

RUSHA

Macquarie Initiates Coverage On F45 Training Holdings with Outperform Rating, Announces Price Target of $25

By Benzinga Newsdesk

Today, 10:52 PM

Macquarie analyst Paul Golding initiates coverage on F45 Training Holdings (NYSE:FXLV) with a Outperform rating and announces Price Target of $25.

FXLV

FDA
News

Journey Medical Corporation Announces First Patient Dosed In Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 Mg) For The Treatment Of Rosacea

By Benzinga Newsdesk

Today, 10:52 PM

Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical"), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of

DERM

Domino’s Russian Franchisee Halts Royalties

Related Posts

SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems

Rush Enterprises Q1 Adj. EPS $1.43 Beats $1.02 Estimate, Sales $1.56B Beat $1.38B Estimate

Macquarie Initiates Coverage On F45 Training Holdings with Outperform Rating, Announces Price Target of $25

Journey Medical Corporation Announces First Patient Dosed In Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 Mg) For The Treatment Of Rosacea